{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:32:46Z","timestamp":1793694766246,"version":"4.5.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute for Medical Research Development (NIMAD) in Iran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01184-8","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T08:43:13Z","timestamp":1752828193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Asieh","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atie Sadat","family":"Khorasanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Amrollahi Bioky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Mohajeri-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Mahmoud","family":"Sajjadi-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"1184_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1573399819666230413094200","volume":"20","author":"A Kumar","year":"2024","unstructured":"Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in india: A review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):105\u201314.","journal-title":"Curr Diabetes Rev"},{"issue":"17","key":"1184_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"key":"1184_CR3","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol. 2024;14:1265372.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1184_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/19322968211035375","volume":"16","author":"K Newlin Lew","year":"2022","unstructured":"Newlin Lew K, Arnold T, Cantelmo C, Jacque F, Posada-Quintero H, Luthra P, et al. Diabetes distal peripheral neuropathy: subtypes and diagnostic and screening technologies. J Diabetes Sci Technol. 2022;16(2):295\u2013320.","journal-title":"J Diabetes Sci Technol"},{"key":"1184_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19:1\u20138.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"1184_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/dmrr.541","volume":"21","author":"H Kamiya","year":"2005","unstructured":"Kamiya H, Murakawa Y, Zhang W, Sima AA. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diab\/Metab Res Rev. 2005;21(5):448\u201358.","journal-title":"Diab\/Metab Res Rev"},{"key":"1184_CR7","doi-asserted-by":"crossref","unstructured":"Gandhi M, Fargo E, Prasad-Reddy L, Mahoney KM, Isaacs D. Diabetes: how to manage diabetic peripheral neuropathy. Drugs Context. 2022;11.","DOI":"10.7573\/dic.2021-10-2"},{"key":"1184_CR8","doi-asserted-by":"crossref","unstructured":"Pop-Busui R, Ang L, Boulton AJ, Feldman EL, Marcus RL, Mizokami-Stout K et al. Diagnosis and treatment of painful diabetic peripheral neuropathy. 2022.","DOI":"10.2337\/db2022-01"},{"issue":"39","key":"1184_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/RXUO6757","volume":"26","author":"S Tesfaye","year":"2022","unstructured":"Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, et al. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technol Assess (Winchester Eng). 2022;26(39):1.","journal-title":"Health Technol Assess (Winchester Eng)"},{"issue":"7","key":"1184_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jphp.13241","volume":"72","author":"MR Khdour","year":"2020","unstructured":"Khdour MR. Treatment of diabetic peripheral neuropathy: a review. J Pharm Pharmacol. 2020;72(7):863\u201372.","journal-title":"J Pharm Pharmacol"},{"key":"1184_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40780-015-0022-7","volume":"1","author":"H Kato","year":"2015","unstructured":"Kato H, Miyazaki M, Takeuchi M, Tsukuura H, Sugishita M, Noda Y, et al. A retrospective study to identify risk factors for somnolence and Dizziness in patients treated with Pregabalin. J Pharm Health Care Sci. 2015;1:1\u20135.","journal-title":"J Pharm Health Care Sci"},{"issue":"4","key":"1184_CR12","doi-asserted-by":"publisher","first-page":"e0284168","DOI":"10.1371\/journal.pone.0284168","volume":"18","author":"M-S Brueckle","year":"2023","unstructured":"Brueckle M-S, Thomas ET, Seide SE, Pilz M, Gonzalez-Gonzalez AI, Dinh TS, et al. Amitriptyline\u2019s anticholinergic adverse drug reactions\u2013A systematic multiple-indication review and meta-analysis. PLoS ONE. 2023;18(4):e0284168.","journal-title":"PLoS ONE"},{"issue":"10","key":"1184_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/antiox9100950","volume":"9","author":"M Caillaud","year":"2020","unstructured":"Caillaud M, Aung Myo YP, McKiver BD, Osinska Warncke U, Thompson D, Mann J, et al. Key developments in the potential of Curcumin for the treatment of peripheral neuropathies. Antioxidants. 2020;9(10):950.","journal-title":"Antioxidants"},{"key":"1184_CR14","doi-asserted-by":"crossref","first-page":"e20200447","DOI":"10.1590\/0001-3765202320230137","volume":"95","author":"RS Silveira","year":"2023","unstructured":"Silveira RS, Baldoni AO, Couto RO, Mendon\u00e7a TS, Domingueti CP. In vivo efficacy of turmeric (Curcuma longa L.) in the treatment of peripheral neuropathy: A systematic review of animal models. An Acad Bras Cienc. 2023;95:e20200447.","journal-title":"An Acad Bras Cienc"},{"key":"1184_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopha.2017.05.099","volume":"92","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Li X, Li Q. Curcumin accelerates the repair of sciatic nerve injury in rats through reducing Schwann cells apoptosis and promoting myelinization. Biomed Pharmacother. 2017;92:1103\u201310.","journal-title":"Biomed Pharmacother"},{"key":"1184_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ctim.2019.02.014","volume":"43","author":"S Asadi","year":"2019","unstructured":"Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano Curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2019;43:253\u201360.","journal-title":"Complement Ther Med"},{"issue":"Supplement1","key":"1184_CR17","first-page":"S17","volume":"45","author":"ADAPP Committee","year":"2022","unstructured":"Committee ADAPP, Committee. ADAPP. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes\u20142022. Diabetes Care. 2022;45(Supplement1):S17\u201338.","journal-title":"Diabetes Care"},{"issue":"5","key":"1184_CR18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2337\/dc21-1074","volume":"45","author":"TS Group","year":"2022","unstructured":"Group TS. Risk factors for diabetic peripheral neuropathy in adolescents and young adults with type 2 diabetes: results from the TODAY study. Diabetes Care. 2022;45(5):1065\u201372.","journal-title":"Diabetes Care"},{"issue":"S 01","key":"1184_CR19","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1055\/a-1284-6245","volume":"129","author":"D Ziegler","year":"2021","unstructured":"Ziegler D, Keller J, Maier C, Pannek J. Diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2021;129(S 01):S70\u201381.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1184_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5868-8-115","volume":"8","author":"PH Lee","year":"2011","unstructured":"Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Activity. 2011;8:1\u201311.","journal-title":"Int J Behav Nutr Phys Activity"},{"issue":"06","key":"1184_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1590\/s0102-865020180060000008","volume":"33","author":"J Lv","year":"2018","unstructured":"Lv J, Cao L, Zhang R, Bai F, Wei P. A Curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1. Acta Cirurgica Brasileira. 2018;33(06):533\u201341.","journal-title":"Acta Cirurgica Brasileira"},{"key":"1184_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fnins.2017.00755","volume":"11","author":"T Jia","year":"2018","unstructured":"Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-encapsulated Curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front NeuroSci. 2018;11:755.","journal-title":"Front NeuroSci"},{"key":"1184_CR23","doi-asserted-by":"crossref","unstructured":"Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine. 2013;9(6):776\u2013\u200985.","DOI":"10.1016\/j.nano.2013.01.001"},{"key":"1184_CR24","doi-asserted-by":"publisher","first-page":"110131","DOI":"10.1016\/j.neuropharm.2024.110131","volume":"260","author":"Z Lin","year":"2024","unstructured":"Lin Z, Wang S, Cao Y, Lin J, Sun A, Huang W, et al. Bioinformatics and validation reveal the potential target of Curcumin in the treatment of diabetic peripheral neuropathy. Neuropharmacology. 2024;260:110131.","journal-title":"Neuropharmacology"},{"key":"1184_CR25","doi-asserted-by":"crossref","unstructured":"Hajimirzaei P, Eyni H, Razmgir M, Abolfazli S, Pirzadeh S, Ahmadi Tabatabaei FS et al. The analgesic effect of Curcumin and nano-curcumin in clinical and preclinical studies: a systematic review and meta-analysis. Naunyn Schmiedebergs Arch Pharmacol. 2024;398(1):393\u2013416.","DOI":"10.1007\/s00210-024-03369-0"},{"key":"1184_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2012.10.001","volume":"74","author":"Y Jeon","year":"2013","unstructured":"Jeon Y, Kim C-E, Jung D, Kwak K, Park S, Lim D, et al. Curcumin could prevent the development of chronic neuropathic pain in rats with peripheral nerve injury. Curr Therapeutic Res. 2013;74:1\u20134.","journal-title":"Curr Therapeutic Res"},{"key":"1184_CR27","doi-asserted-by":"crossref","unstructured":"Di Pierro F, Settembre R. Safety and efficacy of an add-on therapy with Curcumin phytosome and Piperine and\/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen. J Pain Res. 2013;6:497\u2013503.","DOI":"10.2147\/JPR.S48432"},{"issue":"3","key":"1184_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ptr.5014","volume":"28","author":"G Belcaro","year":"2014","unstructured":"Belcaro G, Hosoi M, Pellegrini L, Appendino G, Ippolito E, Ricci A, et al. A controlled study of a lecithinized delivery system of Curcumin (Meriva\u00ae) to alleviate the adverse effects of cancer treatment. Phytother Res. 2014;28(3):444\u201350.","journal-title":"Phytother Res"},{"issue":"9","key":"1184_CR29","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.3390\/ijms22094666","volume":"22","author":"P Basu","year":"2021","unstructured":"Basu P, Maier C, Basu A. Effects of Curcumin and its different formulations in preclinical and clinical studies of peripheral neuropathic and postoperative pain: a comprehensive review. Int J Mol Sci. 2021;22(9):4666.","journal-title":"Int J Mol Sci"},{"key":"1184_CR30","doi-asserted-by":"publisher","first-page":"690533","DOI":"10.3389\/fcvm.2021.690533","volume":"8","author":"GSM Borges","year":"2021","unstructured":"Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S. Nanomedicine in oncocardiology: contribution and perspectives of preclinical studies. Front Cardiovasc Med. 2021;8:690533.","journal-title":"Front Cardiovasc Med"},{"key":"1184_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1922-x","volume":"17","author":"X-S Wang","year":"2017","unstructured":"Wang X-S, Zhang Z-R, Zhang M-M, Sun M-X, Wang W-W, Xie C-L. Neuroprotective properties of Curcumin in toxin-base animal models of parkinson\u2019s disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017;17:1\u201310.","journal-title":"BMC Complement Altern Med"},{"issue":"04","key":"1184_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"G Shoba","year":"1998","unstructured":"Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of Piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Med. 1998;64(04):353\u20136.","journal-title":"Planta Med"},{"issue":"5","key":"1184_CR33","first-page":"567","volume":"6","author":"HR Rahimi","year":"2016","unstructured":"Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG, et al. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomedicine. 2016;6(5):567.","journal-title":"Avicenna J Phytomedicine"},{"issue":"4","key":"1184_CR34","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ptr.6957","volume":"35","author":"M Mokhtari","year":"2021","unstructured":"Mokhtari M, Razzaghi R, Momen-Heravi M. The effects of Curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double\u2010blind, placebo\u2010controlled trial. Phytother Res. 2021;35(4):2099\u2013107.","journal-title":"Phytother Res"},{"issue":"1","key":"1184_CR35","first-page":"8208237","volume":"2019","author":"M Funamoto","year":"2019","unstructured":"Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Kakeya H, et al. Effects of highly absorbable Curcumin in patients with impaired glucose tolerance and non-insulin\u2010dependent diabetes mellitus. J Diabetes Res. 2019;2019(1):8208237.","journal-title":"J Diabetes Res"},{"issue":"5","key":"1184_CR36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/ptr.6328","volume":"33","author":"M Adibian","year":"2019","unstructured":"Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. The effects of Curcumin supplementation on high-sensitivity C\u2010reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double\u2010blind, placebo\u2010controlled trial. Phytother Res. 2019;33(5):1374\u201383.","journal-title":"Phytother Res"},{"issue":"1","key":"1184_CR37","first-page":"77","volume":"24","author":"A Vanaie","year":"2019","unstructured":"Vanaie A, Shahidi S, Iraj B, Siadat ZD, Kabirzade M, Shakiba F, et al. Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. J Res Med Sci. 2019;24(1):77.","journal-title":"J Res Med Sci"},{"key":"1184_CR38","doi-asserted-by":"crossref","unstructured":"Ebrahimzadeh A, Mohseni S, Safargar M, Mohtashamian A, Niknam S, Bakhoda M et al. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med. 2024;80:103025.","DOI":"10.1016\/j.ctim.2024.103025"},{"key":"1184_CR39","doi-asserted-by":"publisher","first-page":"104505","DOI":"10.1016\/j.phrs.2019.104505","volume":"150","author":"A Hadi","year":"2019","unstructured":"Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of curcumin\/turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacol Res. 2019;150:104505.","journal-title":"Pharmacol Res"},{"key":"1184_CR40","doi-asserted-by":"crossref","unstructured":"wen Tang W, fei Huang F, Haedi AR, Shi QY. The effect of Curcumin supplementation on endothelial function and blood pressure in patients with metabolic disorders: a meta-analysis of meta-analyses. Prostaglandins Other Lipid Mediat. 2024;175:106900.","DOI":"10.1016\/j.prostaglandins.2024.106900"},{"issue":"1","key":"1184_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/10408398.2018.1517724","volume":"60","author":"SM Mousavi","year":"2020","unstructured":"Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of Curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(1):171\u201380.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"1184_CR42","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ptr.6312","volume":"33","author":"Z Adab","year":"2019","unstructured":"Adab Z, Eghtesadi S, Vafa MR, Heydari I, Shojaii A, Haqqani H, et al. Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytother Res. 2019;33(4):1173\u201381.","journal-title":"Phytother Res"},{"key":"1184_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-019-0437-7","volume":"11","author":"H Hodaei","year":"2019","unstructured":"Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G. The effect of Curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetol Metab Syndr. 2019;11:1\u20138.","journal-title":"Diabetol Metab Syndr"},{"key":"1184_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clnesp.2020.02.017","volume":"37","author":"S Ebrahimkhani","year":"2020","unstructured":"Ebrahimkhani S, Ghavamzadeh S, Mehdizadeh A. The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: A double-blind, placebo-controlled randomized clinical trial. Clin Nutr ESPEN. 2020;37:178\u201386.","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"1184_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jnutbio.2013.09.013","volume":"25","author":"S Chuengsamarn","year":"2014","unstructured":"Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014;25(2):144\u201350.","journal-title":"J Nutr Biochem"},{"issue":"7","key":"1184_CR46","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1080\/09637486.2021.1885015","volume":"72","author":"JFF Neta","year":"2021","unstructured":"Neta JFF, Veras VS, Sousa DFd C, MdCdSO, Queiroz MVO, Neto JCGL, et al. Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial. Int J Food Sci Nutr. 2021;72(7):968\u201377.","journal-title":"Int J Food Sci Nutr"},{"issue":"6","key":"1184_CR47","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/jc.2008-2385","volume":"94","author":"J Doupis","year":"2009","unstructured":"Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metabolism. 2009;94(6):2157\u201363.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1184_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2337\/dc16-2259","volume":"40","author":"C Herder","year":"2017","unstructured":"Herder C, Kannenberg JM, Huth C, Carstensen-Kirberg M, Rathmann W, Koenig W, et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 study. Diabetes Care. 2017;40(4):569\u201376.","journal-title":"Diabetes Care"},{"issue":"1","key":"1184_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/biof.1874","volume":"49","author":"M Dastani","year":"2023","unstructured":"Dastani M, Rahimi HR, Askari VR, Jaafari MR, Jarahi L, Yadollahi A, et al. Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: evidence of a randomized, double\u2010blinded, placebo\u2010controlled clinical trial. BioFactors. 2023;49(1):108\u201318.","journal-title":"BioFactors"},{"issue":"1","key":"1184_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ptr.7284","volume":"36","author":"AM Gorabi","year":"2022","unstructured":"Gorabi AM, Abbasifard M, Imani D, Aslani S, Razi B, Alizadeh S, et al. Effect of Curcumin on C-reactive protein as a biomarker of systemic inflammation: an updated meta\u2010analysis of randomized controlled trials. Phytother Res. 2022;36(1):85\u201397.","journal-title":"Phytother Res"},{"key":"1184_CR51","doi-asserted-by":"crossref","unstructured":"Banait T, Wanjari A, Danade V, Banait S, Jain J. Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review. Cureus. 2022;14(10).","DOI":"10.7759\/cureus.30225"},{"issue":"4","key":"1184_CR52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/1389200211314040012","volume":"14","author":"MM Yallapu","year":"2013","unstructured":"Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC. Plasma proteins interaction with Curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab. 2013;14(4):504\u201315.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"1184_CR53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamaneurol.2017.4609","volume":"75","author":"CP Hor","year":"2018","unstructured":"Hor CP, Fung WY, Ang HA, Lim SC, Kam LY, Sim S-W, et al. Efficacy of oral mixed tocotrienols in diabetic peripheral neuropathy: a randomized clinical trial. JAMA Neurol. 2018;75(4):444\u201352.","journal-title":"JAMA Neurol"},{"key":"1184_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40200-016-0229-7","volume":"15","author":"HR Fateh","year":"2015","unstructured":"Fateh HR, Madani SP, Heshmat R, Larijani B. Correlation of Michigan neuropathy screening instrument, united Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. J Diabetes Metabolic Disorders. 2015;15:1\u20135.","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"1","key":"1184_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.imlet.2015.09.009","volume":"168","author":"NM Janahi","year":"2015","unstructured":"Janahi NM, Santos D, Blyth C, Bakhiet M, Ellis M. Diabetic peripheral neuropathy, is it an autoimmune disease? Immunol Lett. 2015;168(1):73\u20139.","journal-title":"Immunol Lett"},{"issue":"6","key":"1184_CR56","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","volume":"41","author":"MJ Hjermstad","year":"2011","unstructured":"Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manag. 2011;41(6):1073\u201393.","journal-title":"J Pain Symptom Manag"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01184-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:48:10Z","timestamp":1757260090000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01184-8","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol (available at nimad.ac.ir) was approved by the National Institute for Medical Research Developments Ethics Committee, and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}